Ingevity Corporation
NGVT
$71.98
$1.061.50%
NYSE
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 1.14% | -23.42% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 1.14% | -23.42% | |||
| Cost of Revenue | -15.36% | -16.01% | |||
| Gross Profit | 32.57% | -34.43% | |||
| SG&A Expenses | -2.16% | -5.67% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -12.62% | -13.58% | |||
| Operating Income | 77.84% | -53.14% | |||
| Income Before Tax | 128.68% | -269.29% | |||
| Income Tax Expenses | 125.66% | -223.83% | |||
| Earnings from Continuing Operations | 129.70% | -293.14% | |||
| Earnings from Discontinued Operations | 727.59% | -314.81% | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 170.69% | -294.48% | |||
| EBIT | 77.84% | -53.14% | |||
| EBITDA | 35.74% | -38.56% | |||
| EPS Basic | 171.57% | -297.79% | |||
| Normalized Basic EPS | 679.80% | -89.45% | |||
| EPS Diluted | 169.99% | -302.24% | |||
| Normalized Diluted EPS | 663.34% | -89.26% | |||
| Average Basic Shares Outstanding | -1.24% | -1.68% | |||
| Average Diluted Shares Outstanding | 0.89% | -3.40% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||